Nobel Prize winner, Laureate Frances Arnold’s address at SynBioBeta 2019

2019 was yet another pioneering year for synthetic biology, characterized by sustained growth even beyond the silicon microchip boom Moore's Law Curve. From a refined version of CRISPR (prime editing) and improved DNA data storage to a more synthetic biology policy focus and new control of metabolic pathways, the field is accelerating at an ever-increasing rate to catalyze progress in apparently every arena of life.

Early October....